Metabolic risk factors, drugs, and obesity.
Padwal
Raj
R
Majumdar
Sumit
S
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D050171:Dyslipidemias / Q000150:complications / Q000188:drug therapy*; D018149:Glucose Intolerance / Q000188:drug therapy; D006801:Humans; D009765:Obesity / Q000150:complications / Q000188:drug therapy*; D050177:Overweight; D010880:Piperidines / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D000077285:Rimonabant; D015431:Weight Loss / Q000187:drug effects
D019440:Anti-Obesity Agents; D010880:Piperidines; D011720:Pyrazoles; D000077285:Rimonabant